Clinical Trials
Peregrine reports results from phase II front-line lung cancer trial
Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed to determine overall response rate of carboplatin and paclitaxel with...
Clinical Trials
Circassia reports positive results from Phase II ragweed allergy therapy study
Circassia, a specialty biopharmaceutical company, has announced positive results from Phase II clinical trial of ragweed allergy therapy. According to...
Clinical Trials
PhaseBio begins Phase I hypertension study with Vasomera
PhaseBio Pharmaceuticals, a biotechnology company, has initiated Phase I clinical study with its novel compound, Vasomera (PB1046), in patients with Stage 1 and 2...
Clinical Trials
TxCell reports positive immuno-monitoring results from Phase I/II Crohn’s disease study
TxCell SA, a biotechnology company, has announced positive immuno-monitoring results of the Phase I/II study in Crohn's disease with Ovasave. ...
Clinical Trials
Galena initiates Phase III PRESENT trial for NeuVax
Galena Biopharma has initiated Phase III trial for NeuVax (E75 peptide plus GM-CSF) vaccine in HER2 1+ and 2+ breast cancer patients in the...
Clinical Trials
Genta reports Tesetaxel Phase 2b trial data
Genta's Tesetaxel has demonstrated efficacy in the Phase 2b, confirmatory clinical trial, designed to evaluate the drug in patients with advanced gastric cancer. ...
Clinical Trials
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C) were...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.